# Processa Pharmaceuticals, Inc.: Form 10-K/A for the period ended Dec 31, 2021

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 10-K/A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 15:55 ET
- Period: 2021-12-31
- Accession: 0001493152-22-011777
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315222011777/form10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315222011777/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315222011777/form10ka.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-011777. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
